ACM
PLSE icon

Aster Capital Management’s Pulse Biosciences PLSE Stock Holding History

Aster Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-105
Closed -$1.69K – 1162
2026
Q1 		$1.69K Buy
105
+44
+72% +$812 ﹤0.01% 762
2025
Q4 		$838 Sell
61
-173
-74% -$2.7K ﹤0.01% 1008
2025
Q3 		$4.14K Sell
234
-261
-53% -$4.13K ﹤0.01% 821
2025
Q2 		$7.47K Sell
495
-410
-45% -$6.8K ﹤0.01% 824
2025
Q1 		$16.6K Buy
905
+880
+3,520% +$16.4K ﹤0.01% 1008
2024
Q4 		$435 Sell
25
-52
-68% -$917 ﹤0.01% 1040
2024
Q3 		$1.35K Buy
+77
New +$1.31K ﹤0.01% 995

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Aster Capital Management's PLSE Position: Q2 2026 in Review

Aster Capital Management sold out of Pulse Biosciences (PLSE) in Q2 2026, closing a stake of 105 shares — an estimated $1.69K sold.

Aster Capital Management first reported a position in PLSE in Q3 2024 and held it in 7 quarters. The position peaked at $16.6K in Q1 2025. 105 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Aster Capital Management reported no remaining Pulse Biosciences position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 105 Pulse Biosciences shares in Q2 2026, an estimated $1.69K.
  • Aster Capital Management first reported a position in Pulse Biosciences in Q3 2024 and held it in 7 quarters.
  • Aster Capital Management's Pulse Biosciences position peaked at $16.6K in Q1 2025.
  • 105 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.